scholarly journals Nuclear Medicine in the Imaging and Management of Breast Cancer

10.5772/22648 ◽  
2011 ◽  
Author(s):  
Luciano Izzo ◽  
Sara Savelli ◽  
Andrea Stagnitti ◽  
Mario Marini
Keyword(s):  
Breast Cancer ◽  
Nuclear Medicine

scholarly journals Death anxiety among women with breast cancer at the National Center for Radiotherapy and Nuclear Medicine in Khartoum: قلق المَوْت لدى المُصَابَاتِ بِسرطانِ الثَّدْي، بالمَرْكَزِ القَوْمِيّ للعِلاجِ بالأَشِعَةِ وَالطِّبّ النَّوَوِيّ بِالخرطوم

2021 ◽  
Vol 5 (30) ◽  
pp. 147-161
Author(s):  
Soha Mohamed Ali, Elrasheed Ismaeil Eltahir Soha Mohamed Ali, Elrasheed Ismaeil Eltahir
Keyword(s):  
Social Sciences ◽  
Breast Cancer ◽  
Nuclear Medicine ◽  
Sample Size ◽  
Death Anxiety ◽  
Negative Emotions ◽  
Anxiety Scale ◽  
The Social ◽  
The Family ◽  
Descriptive Method

This study addressed death anxiety among women with breast cancer at the National Center for Radiotherapy and Nuclear Medicine in Khartoum, in order to identify: differences in death anxiety among women with breast cancer according to the variable of performing mastectomy at the Center. Where They used the descriptive method with a sample size 35 women with breast cancer were chosen by the intentional method at the Center, they applied the death anxiety scale on the patients, the data was analysed statistically using statistical package for the social sciences (SPSS). They reached a number of conclusions and recommendation, including: The death anxiety among women with breast cancer at the Center is high, there are statistically significant differences between death anxiety among women with breast cancer at the Center according to the variable of performing mastectomy in favor of those who underwent a mastectomy. Guidance should be offered to the family and especially the husband to how to deal with his injured wife according to her stage and accept the apparent negative emotions and behaviors, and encourage her to express herself.

scholarly journals (Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer

2020 ◽  
Vol 13 (3) ◽  
pp. 39
Author(s):  
Irina Velikyan
Keyword(s):  
Breast Cancer ◽  
Prostate Cancer ◽  
Nuclear Medicine ◽  
Personalized Medicine ◽  
Patient Management ◽  
Neuroendocrine Neoplasms ◽  
Medicine Development ◽  
Oncological Patients

The role of nuclear medicine in the management of oncological patients has expanded during last two decades. The number of radiopharmaceuticals contributing to the realization of theranostics/radiotheranostics in the context of personalized medicine is increasing. This review is focused on the examples of targeted (radio)pharmaceuticals for the imaging and therapy of neuroendocrine neoplasms (NENs), prostate cancer, and breast cancer. These examples strongly demonstrate the tendency of nuclear medicine development towards personalized medicine.

scholarly journals The role of general nuclear medicine in breast cancer

2015 ◽  
Vol 62 (1) ◽  
pp. 54-65 ◽  
Author(s):  
Lacey R. Greene ◽  
Deborah Wilkinson
Keyword(s):  
Breast Cancer ◽  
Nuclear Medicine

Nuclear medicine in breast cancer diagnostics: Primary tumor and lymphatic metastasis

2017 ◽  
Author(s):  
I. Sinilkin ◽  
A. Medvedeva ◽  
V. Chernov ◽  
E. Slonimskaya ◽  
R. Zelchan ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Nuclear Medicine ◽  
Lymphatic Metastasis ◽  
Primary Tumor ◽  
Cancer Diagnostics ◽  
Breast Cancer Diagnostics

scholarly journals The Added Benefit of Hybrid SPECT/CT in the Diagnosis of Bone Metastasis in Patients with Breast Cancer

2015 ◽  
Vol 17 (1) ◽  
pp. 38-49
Author(s):  
Nasim Khan ◽  
SM Moinul Islam ◽  
Abrar Al Sakib ◽  
Saiyeeda Mahmood ◽  
Gazi Abul Hossian ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Computed Tomography ◽  
Nuclear Medicine ◽  
Breast Carcinoma ◽  
Cancer Patients ◽  
Bone Scintigraphy ◽  
Whole Body ◽  
Emission Computed Tomography ◽  
Breast Cancer Patients ◽  
Medicine Physician

The purpose of this study was to investigate the additional benefit of single photon emission computed tomography/computed tomography (SPECT/CT) over whole-body planar bone scintigraphy (planar BS) and SPECT for the detection of bone metastases in breast cancer patients. Materials & methods: Of 112 consecutively examined patients with histologically confirmed breast carcinoma who underwent bone scintigraphy, 39 required further evaluation by SPECT/CT (n= 23) and SPECT alone (n = 16) because a definite diagnosis could not be established using whole body planar BS alone. The 23 SPECT/CT studies were retrospectively evaluated by two nuclear medicine physicians for planar BS and SPECT images, and one nuclear medicine physician and one radiologist for SPECT/CT on consensus. Each focus of abnormal tracer uptake was recorded for differentiating malignant from benign bone lesions. Clinical and imaging follow-up were used as a reference standard. Results: A total of 72 lesions were evaluated in 23 patients examined by three types of imaging modalities. In 57 of the 72 evaluated lesions, the results of planar BS, SPECT and SPECT/CT were concordant; 52 of the 57 lesions were interpreted as malignant and 5 lesions as benign by all modalities. In 15 of the 72 lesions, consensus reading of fused SPECT/CT images changed the image interpretation of 15 planar BS scans and 9 of the 15 SPECT scans: 7 lesions previously interpreted as benign (on both planar BS and SPECT) were re-classified as malignant and 8 lesions (8 by planar BS and 2/8 by SPECT) previously interpreted as malignant were reevaluated as benign. The highest diagnostic gain was in the thoracolumbar spine, thoracic cage & pelvis. The overall accuracy of SPECT/CT was significantly higher on a lesion-based analysis than planar BS and SPECT (100%vs 79%, p < 0.0001 and 100% vs 83%, p = 0.003). Compared to planar BS and SPECT, the results of SPECT/CT changed diagnosis or treatment in 5/23 patients (21.7%). 39 Conclusion: The hybrid imaging system with SPECT/CT is a feasible technique yielding coregistered dual-modality images. The addition of SPECT/CT improves the diagnostic accuracy for the correct interpretation of bony lesions in breast cancer patients undergoing bone scanning for metastases. SPECT/CT should be routinely used in the work up of postoperative breast carcinoma patients with simultaneous CT evaluation to identify metastatic lesions not detected on bone scintigraphy. DOI: http://dx.doi.org/10.3329/bjnm.v17i1.22490 Bangladesh J. Nuclear Med. 17(1): 38-49, January 2014

Sign in / Sign up

Export Citation Format

Share Document